Terms: = Colorectal cancer AND LRIG3, Q6UXM1, 121227, ENSG00000139263, FLJ90440, KIAA3016, FLJ26573
2 results:
1. lrig3 represses cell motility by inhibiting slug via inactivating ERK signaling in human colorectal cancer.
Zeng K; Chen X; Xu M; Liu X; Li C; Xu X; Pan B; Qin J; He B; Pan Y; Huiling S; Xu T; Wang S
IUBMB Life; 2020 Jul; 72(7):1393-1403. PubMed ID: 32107843
[TBL] [Abstract] [Full Text] [Related]
2. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
